Error: Could not add to watchlist. X

Bellevue Funds Lux - BB Adamant Biotech

+ Watchlist
M0U2:GR
Frankfurt
499.27
EUR
8.71
1.78%
As of 13:47:53 ET on 07/07/2015.
Open
496.85
Day Range
491.96 - 499.27
Volume
0
Previous Close
490.56
52Wk Range
254.91 - 530.26
1 Yr Return
86.24%
NAV (on -)
-
Total Assets (m EUR) (on 07/06/2015)
105.595
Inception Date
03/31/2009
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
CHRISTIAN LACH
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
-
3 Mo Return
2.52%
3 Yr Return
46.49%
5 Yr Return
35.73%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 20.00 k 7.94 m 8.09
Gilead Sciences Inc 68.00 k 7.63 m 7.78
Celgene Corp 63.00 k 7.21 m 7.35
Amgen Inc 30.87 k 4.82 m 4.92
Regeneron Pharmaceuticals Inc 9.40 k 4.82 m 4.91
Mylan NV 55.00 k 3.99 m 4.07
Vertex Pharmaceuticals Inc 28.50 k 3.66 m 3.73
Alexion Pharmaceuticals Inc 20.75 k 3.40 m 3.47
Medivation Inc 24.30 k 3.21 m 3.27
Illumina Inc 15.56 k 3.21 m 3.27
Profile
Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.
ADDRESS
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
PHONE
41-44-267-67-00